Evaluation of methemoglobin as an autologous intravascular MRI contrast agent

Magn Reson Med. 1996 May;35(5):787-9. doi: 10.1002/mrm.1910350521.

Abstract

Methemoglobin (MetHb) was evaluated as an intravascular paramagnetic contrast agent. Methemoglobin formation was induced by 4-dimethylaminophenol (4-DMAP), causing a reduction in blood T2* in vitro. The 4-DMAP generated metHb with a time constant of 62 s. A 4-DMAP bolus did not decrease measurably the signal intensity in the in vivo rabbit kidney in the first pass. At steady state, a MetHb concentration of 24.8 +/- 2.3% resulted in a signal decrease of 9.2 +/- 2.6% in the kidney. Methemoglobin is an effective vascular T2* relaxation agent, but the formation of MetHb by 4-DMAP is too slow for first-pass imaging. A more effective conversion agent resulting in a bolus of at least 25% MetHb within 5 s would result in a detectable first-pass signal and a viable contrast technique.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 4-Aminopyridine / analogs & derivatives
  • Animals
  • Contrast Media*
  • Dogs
  • Gadolinium DTPA
  • Image Processing, Computer-Assisted
  • Kidney / anatomy & histology*
  • Magnetic Resonance Imaging / methods*
  • Methemoglobin*
  • Organometallic Compounds
  • Pentetic Acid / analogs & derivatives
  • Rabbits

Substances

  • Contrast Media
  • Organometallic Compounds
  • Pentetic Acid
  • Methemoglobin
  • 4-Aminopyridine
  • Gadolinium DTPA
  • 4-dimethylaminopyridine